Skip to content
Review Open access

AI-Driven Multi-Omics Integration for Early Disease Detection: A Comprehensive Survey

Aug 2026 · International Journal of Advanced Research in Science, Communication and Technology · 0 citations

TL;DR

By comparing genomic and multi-omics strategies, this survey highlights ongoing hurdles related to privacy, bias, interpretability, and scalability.

Abstract

artificial intelligence (AI) is transforming the way we stumble on ailments early, but relying on a single form of facts—which includes genomics on my own—offers most effective a restrained picture of the whole organic complexity. Multi-omics integration—alongside aspect genomics, transcriptomics, proteomics, metabolomics, microbiome information, and scientific signs and symptoms and signs and symptoms—offers a more whole view of illness improvement. modern-day-day research show that graph neural networks (GNNs), federated getting to know (FL), and explainable AI (XAI) outperform genomic-most effective models through identifying novel biomarkers and enhancing diagnostic accuracy. Examples embody Tab net fusion for Alzheimer’s, multimodal deep reading for rheumatoid arthritis, and semi-supervised analyzing for hepatocellular carcinoma. By comparing genomic and multi-omics strategies, this survey highlights ongoing hurdles related to privacy, bias, interpretability, and scalability. destiny tips which consist of transformer-based fusion and basis fashions promise equitable, transparent, and clinically relevant AI-driven multi-omics structures for precision medicine.

Read PDF

Similar papers

Review Open access Jul 2026

Artificial Intelligence-Driven Multi-Omics Diagnostic Pipelines for Infectious, Neurodegenerative, and Metabolic Diseases: From Biomarker Discovery to Precision Medicine and Digital Twin Healthcare

This review aims to summarize the current status of the artificial intelligence (AI)-based multi-omics diagnostic workflows employed in three disease paradigms: infectious, neurodegenerative, and metabolic diseases, and critically evaluate their translational potential from the discovery of biomarkers to digital twin h...

Emmanuel Nkansah, M. Oladosu, M. Abah et al. · 0 citations
Review Aug 2026

Artificial Intelligence-Driven Multiomics Integration in Lung Cancer: From Data Convergence to Precision Phenomics.

Precision phenomics is introduced as a unifying framework that links molecular, spatial, functional, and clinical characteristics of tumors to support personalized cancer management and has the potential to transform lung cancer research and improve patient outcomes.

Sanjukta Dasgupta, D. De · 0 citations
Review Jul 2026

AI-Driven Multi-Omics Integrated Applications Using Diverse Neural Networks for Breast Cancer Diagnostic Screening and Biomarker Discovery.

Recent developments in AI-driven multi-omics approaches for the discovery of BC biomarkers are summarized and future perspectives on the integration of AI and multi-omics to revolutionize precision clinical medicine and improve clinical outcomes in BC theranostics are outlined.

V. Kumari, Harshita Tiwari, Swati Singh et al. · 2 citations
Review Open access Aug 2026

Machine learning and AI for cancer research and care: a review of applications, limitations, and future directions

This review synthesizes key developments in ML for oncology, covering foundational algorithms alongside emerging approaches, and describes future directions, including federated learning, graph neural networks, longitudinal modeling, and integration of real-world and wearable data to support precision oncology.

Kanishk Yadav, Taneesha Gupta · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.